Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies for cell therapy manufacturing to meet the total patient demand for cell therapies globally.

Cellares

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.

Eclipse Ventures

EcoR1 Capital

Skyviews Life Science

Decheng Capital

Willett Advisors LLC

Koch Disruptive Technologies

Bristol-Myers Squibb

DFJ Growth

Rodney L Rietze, PhD, Co-Founder and CEO of iVexSol, and Cellares Advisory Board Member, discusses how an Integrated Development Manufacturing Organization's (IDMO) transformative technology seamlessly integrate unit operations and break the bottlenecks of cell therapy manufacturing scalability.

Watch the full video here: https://lnkd.in/gNYwsE3U

ℹ️ Cellares TAP Program is ending soon ℹ️

#IDMO #celltherapymanufacturing
https://lnkd.in/e7Xb8ANt

Watch Timothy Moore, CTO at Allogene Therapeutics and Cellares Advisory Board Member, discuss the constraints of conventional CDMOs and how an Integrated Development and Manufacturing Organization (IDMO) can help the industry scale manufacturing to meet the global patient demand for cell therapies.

Click here to see the full interview:

https://lnkd.in/gzbVQPw7

Cellares’ Series C Fundraising Triumph: Launching A New Smart Factory In Somerset County, NJ

Learn more & get our take 👇
https://lnkd.in/gHcrUnm3

“We’re excited to welcome Cellares to the life sciences hub of New Jersey,” – Shanel Robinson, Commissioner Director at Somerset County

“The opening of this facility marks a tremendous milestone towards Cellares’ mission of accelerating access to life-saving cell therapies to meet total global patient demand,” – John Tomtishen, Sr. Vice President and General Manager at Bridgewater IDMO Smart Factory

“Not only does Cellares join a thriving Life Sciences industry here, but they reinforce the fact that many of the cures needed by the world come from Somerset County,” – Jessica Paolini, Manager of Economic Development at Somerset County

#funding #lifesciences #SoHCNews

COM:CELLARES

Cellares

locale

market

industry

website

crunchbase

linkedin

founding date

investor of

competitor of

Metrics